Xtant Medical Holdings, Inc. (XTNT) stock

XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3075% below fair value

$0.28−0.00 (-0.94%)

Close on Nov 12, 2026Market cap $38.62MP/E –Yield –

Xtant Medical EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Xtant Medical's EV/EBITDA was 7.5× on Jul 31, 2026, against 42.1× a year earlier. Over the last 2 years it ranged from 5.7× to 263.8×, with a median of 42.1×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Jul 31, 2026	7.5×	−3.2
2025	Dec 31, 2025	10.7×	−31.4
2021	Oct 29, 2021	42.1×	−38.2
2020	Dec 31, 2020	80.3×	–

Where these numbers come from

Parsed from the XBRL in Xtant Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Feb 14, 2018
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing